This early-stage trial tests a new drug called SON-1010 in about 42 adults with advanced solid tumors that have spread. The main goals are to check the drug's safety and find the highest dose that can be given without causing severe side effects. Researchers will also measure how…
Phase: PHASE1 • Sponsor: Sonnet BioTherapeutics • Aim: Disease control
Last updated May 17, 2026 05:04 UTC